- Home
- TSAT vs FBIOP Comparison
TSAT vs FBIOP Comparison
Compare TSAT & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSAT
- FBIOP
- Stock Information
- Founded
- TSAT 1969
- FBIOP N/A
- Country
- TSAT Canada
- FBIOP United States
- Employees
- TSAT N/A
- FBIOP 101
- Industry
- TSAT Metal Fabrications
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- TSAT Industrials
- FBIOP Health Care
- Exchange
- TSAT Nasdaq
- FBIOP Nasdaq
- Market Cap
- TSAT N/A
- FBIOP N/A
- IPO Year
- TSAT 1996
- FBIOP N/A
- Fundamental
- Price
- TSAT $15.77
- FBIOP $6.15
- Analyst Decision
- TSAT
- FBIOP
- Analyst Count
- TSAT 0
- FBIOP 0
- Target Price
- TSAT N/A
- FBIOP N/A
- AVG Volume (30 Days)
- TSAT 79.1K
- FBIOP N/A
- Earning Date
- TSAT 05-06-2025
- FBIOP N/A
- Dividend Yield
- TSAT N/A
- FBIOP N/A
- EPS Growth
- TSAT N/A
- FBIOP N/A
- EPS
- TSAT N/A
- FBIOP N/A
- Revenue
- TSAT $372,642,710.00
- FBIOP N/A
- Revenue This Year
- TSAT N/A
- FBIOP N/A
- Revenue Next Year
- TSAT N/A
- FBIOP N/A
- P/E Ratio
- TSAT N/A
- FBIOP N/A
- Revenue Growth
- TSAT N/A
- FBIOP N/A
- 52 Week Low
- TSAT $7.18
- FBIOP N/A
- 52 Week High
- TSAT $25.38
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- TSAT 43.04
- FBIOP 47.56
- Support Level
- TSAT $14.77
- FBIOP $6.36
- Resistance Level
- TSAT $17.32
- FBIOP $6.80
- Average True Range (ATR)
- TSAT 1.12
- FBIOP 0.37
- MACD
- TSAT 0.08
- FBIOP 0.01
- Stochastic Oscillator
- TSAT 33.90
- FBIOP 45.52
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.